Abstract 3911: Use of ALK inhibitors in patients with non-lung malignancies bearing <i>ALK</i> alteration prolongs treatment duration.Vitor Góes, Sumanta Kumar Pal, Vicki Doctor et al.|Cancer Research|2026Cited by 0